Valuation: INSTITUT

Market Cap 4.4B 52.47M 46.59M 43.44M 39.6M 74.79M 5.05B 75.41M 526M 204M 2.58B 197M 193M 8.27B P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 4.64B 55.26M 49.07M 45.75M 41.71M 78.78M 5.32B 79.43M 554M 215M 2.71B 207M 203M 8.72B EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 2.02%
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 23/08/2010
Director/Board Member 47 09/01/2014
Director/Board Member 45 01/01/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%-3.00%+11.58%+25.34% 111B
+0.78%-2.05%-0.66%+75.33% 92.38B
+0.46%-0.54%+145.20%+850.76% 59.15B
-0.38%-5.45%-7.47%+54.41% 27.66B
+0.97%-1.27%+30.11%+90.35% 25.75B
+1.28%-0.37%+11.39%+53.28% 25.02B
-0.67%-0.58%-16.34%-7.26% 20.99B
+1.83%-0.42%+27.40%+322.31% 20.82B
+1.30%-2.86%-4.06%+34.25% 16.87B
Average +0.78%-1.83%+21.90%+166.53% 44.36B
Weighted average by Cap. +0.89%-2.05%+27.10%+181.31%

Financials

2024 2025
Net sales 1.52B 18.14M 16.1M 15.02M 13.69M 25.86M 1.75B 26.07M 182M 70.61M 891M 68.08M 66.61M 2.86B 1.72B 20.46M 18.17M 16.94M 15.44M 29.16M 1.97B 29.4M 205M 79.64M 1B 76.79M 75.14M 3.23B
Net income 215M 2.56M 2.27M 2.12M 1.93M 3.65M 247M 3.68M 25.69M 9.97M 126M 9.62M 9.41M 404M 96.95M 1.16M 1.03M 957K 872K 1.65M 111M 1.66M 11.59M 4.5M 56.75M 4.34M 4.24M 182M
Net Debt 199M 2.37M 2.11M 1.97M 1.79M 3.39M 229M 3.41M 23.81M 9.24M 117M 8.91M 8.72M 375M 234M 2.8M 2.48M 2.31M 2.11M 3.99M 269M 4.02M 28.03M 10.88M 137M 10.49M 10.27M 441M
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-